| Product Type | Impurity Standards |
| CAT. No. | MRL-R18016 |
| CAS. No. | NA |
| Mol. Formula | C13H19N3O3 |
| Mol. Weight | 265.31 |
| Synonyms | NA |
| Chemical Name | (S)-3-(1-(Methyl(nitroso)amino)ethyl)phenyl ethyl(methyl)carbamate |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In stock |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Rivastigmine. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Rivastigmine is a medication used in the treatment of Alzheimers disease and Parkinsons disease-related dementia. Structurally, it is a carbamate derivative. Rivastigmine belongs to the class of acetylcholinesterase inhibitors, and its primary mechanism of action involves increasing levels of acetylcholine, a neurotransmitter involved in cognitive function, by inhibiting its breakdown. This is particularly beneficial in conditions where there is a deficiency of acetylcholine, as seen in Alzheimers and Parkinsons disease-related dementia. Rivastigmine is available in various formulations, including oral capsules and transdermal patches, allowing for flexibility in administration. Buy high quality N-Nitroso Rivastigmine Hydrogen Tartarate EP Impurity E from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Rivastigmine Hydrogen Tartarate EP Impurity E.